Glucose in Dialysis Water in Diabetics With Chronic Renal Failure

• Register: ClinicalTrials.gov
• Last refreshed on: 28 September 2015
• Main ID: NCT00438503
• Date of registration: 20/02/2007
• Prospective Registration: No
• Primary sponsor: Regional Hospital Holstebro
• Public title: Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
• Scientific title: Effect of Glucose in Dialysis Water in Diabetics With Chronic Renal Failure on Blood Pressure, Pulse Rate, Plasma Glucose, Plasma Concentrations of Insulin, Growth Hormone, Renin, Angiotensin II, Endothelin and Body Temperature
• Date of first enrolment: May 2006
• Target sample size: 18
• Recruitment status: Completed
• URL: https://clinicaltrials.gov/show/NCT00438503
• Study type: Interventional
• Study design: Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment
• Phase: Phase 4

Countries of recruitment

Denmark

Contacts

• Name: Erling B Pedersen, Professor
• Affiliation: Regional Hospital Holstebro

Key inclusion & exclusion criteria

Inclusion Criteria:

1. Age > 18 years,

2. Both men and women,

3. Dialysis treatment for at least three month due to diabetic nephropathy

Exclusion Criteria:

1. Heart failure,

2. Lung insufficiency,

3. Chronic liver disease,

4. Malignant disease,

5. Nephrotic syndrome,

6. Lack of compliance,

7. Unwillingness to participate



Age minimum: 18 Years
Age maximum: N/A
Gender: Both

Health Condition(s) or Problem(s) studied

Diabetic Nephropathies

Renal Failure, Chronic

Intervention(s)

Procedure: Procedure

Primary Outcome(s)

Effect og glucose in dialysis water on blood pressure, plasma glucose and hormones in plasma

Secondary Outcome(s)

Relationship between changes in blood pressure and and changes in hormones

Secondary ID(s)

MED.RES.2007.02.EBP

Source(s) of Monetary Support

Please refer to primary and secondary sponsors